文献速递骨质疏松与钙磷/甲状旁腺性腺与生殖内分泌

妊娠与哺乳期血钙变化及甲状旁腺功能减退症治疗的单中心病例系列

Changes in Serum Calcium and Treatment of Hypoparathyroidism During Pregnancy and Lactation: A Single-center Case Series.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该单中心回顾性病例系列纳入19例孕前诊断甲状旁腺功能减退症(hypo-PT)患者共25次妊娠,分析妊娠期血钙变化及不良妊娠结局。妊娠期仅部分患者血钙改善或恶化,不良妊娠结局发生率为30.4%;哺乳期血钙和24小时尿钙较妊娠期显著升高,41.7%的哺乳患者在产后2个月内出现高钙血症。

要点

  • 妊娠期hypo-PT患者血钙可改善、恶化或稳定,需密切监测以维持适宜血钙水平。
  • 该系列不良妊娠结局发生率为30.4%,包括早产和流产。
  • 哺乳期血钙和尿钙显著升高,41.7%哺乳患者产后2个月内发生高钙血症,应考虑减药。

核心结论

  • 甲状旁腺功能减退症女性患者妊娠期钙稳态变化不一,不良妊娠结局发生率较高,应密切监测以维持最佳血钙水平。
  • 哺乳期血钙和24小时尿钙较妊娠期显著升高,产后2个月内高钙血症常见,应考虑减少药物剂量以避免高钙血症。

研究设计与样本

  • 单中心回顾性病例系列研究,来自中国大陆单中心,纳入孕前诊断甲状旁腺功能减退症的19例患者共25次妊娠。
  • 收集起病时及妊娠期前后的临床特征和治疗策略数据。

主要发现

  • 妊娠期除2例数据缺失外,5例患者6次妊娠(6/23,26.1%)血钙升高定义为病情改善,4例患者4次妊娠(4/23,17.4%)血钙下降超过0.2 mmol/L定义为病情恶化,3例患者3次妊娠(3/23,13.0%)病情稳定。
  • 不良妊娠结局发生率为30.4%(4/23为早产,3/23为流产)。
  • 哺乳期血钙和24小时尿钙较妊娠期显著升高(2.57 ± 0.34 vs 1.99 ± 0.11 mmol/L,P < 0.001;12.28 ± 5.41 vs 8.63 ± 3.22 mmol/L,P = 0.013)。
  • 5例患者5次哺乳(5/12,41.7%)在产后2个月内发生高钙血症。

关键数值与推荐

  • 病情改善定义为血钙水平升高。
  • 病情恶化定义为血钙水平下降超过0.2 mmol/L。
  • 不良妊娠结局包括早产(4/23)和流产(3/23)。
  • 哺乳期高钙血症定义为产后2个月内发生高钙血症,5/12次哺乳(41.7%)。

临床怎么用

  • 妊娠期应密切监测血钙以维持最佳血清钙水平。
  • 哺乳期应考虑减少药物剂量以避免高钙血症。

局限性

  • 单中心回顾性病例系列,样本量有限。
  • 部分患者妊娠期数据缺失(2例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoparathyroidism (hypo-PT) is rare, and studies on hypo-PT, especially during pregnancy and lactation, are limited. DESIGN AND SETTING: This was a retrospective study on a relatively large case series in a single center from mainland China. METHODS: A total of 19 patients with 25 pregnancies, diagnosed with hypo-PT before pregnancy, were enrolled. Data on clinical characteristics and treatment strategies at onset time and around pregnancy period were collected. RESULTS: During pregnancy, except for 2 patients with missing data, 5 patients with 6 pregnancies (6/23, 26.1%) experienced improved hypo-PT condition, defined as an increased serum calcium level; 4 patients with 4 pregnancies (4/23, 17.4%) experienced worsened hypo-PT condition, defined as a more than 0.2 mmol/L decline in the serum calcium level; and 3 patients with 3 pregnancies (3/23, 13.0%) remained in stable hypo-PT condition. The prevalence of adverse pregnancy outcomes was 30.4% (4/23 for preterm delivery; 3/23 for miscarriage). The serum calcium and 24-hour urine calcium levels significantly increased during lactation compared with pregnancy (2.57 ± 0.34 vs 1.99 ± 0.11 mmol/L, P < 0.001; 12.28 ± 5.41 vs 8.63 ± 3.22 mmol/L, P = 0.013), and 5 patients with 5 lactations (5/12, 41.7%) developed hypercalcemia in the first 2 months after delivery. CONCLUSIONS: Female patients with hypo-PT had different changes in calcium homeostasis and a high prevalence of adverse outcomes during pregnancy. Thus, they should be monitored closely to maintain the optimal serum calcium level. Decreasing drug dosage during the lactation period should be considered to avoid hypercalcemia.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang JJ, Wang O, Wang YB, et al. Changes in Serum Calcium and Treatment of Hypoparathyroidism During Pregnancy and Lactation: A Single-center Case Series. J Clin Endocrinol Metab. 2021. PMID: 34279662. doi:10.1210/clinem/dgab530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。